Your browser doesn't support javascript.
loading
Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Christakoudi, Sofia; Pagoni, Panagiota; Ferrari, Pietro; Cross, Amanda J; Tzoulaki, Ioanna; Muller, David C; Weiderpass, Elisabete; Freisling, Heinz; Murphy, Neil; Dossus, Laure; Turzanski Fortner, Renee; Agudo, Antonio; Overvad, Kim; Perez-Cornago, Aurora; Key, Timothy J; Brennan, Paul; Johansson, Mattias; Tjønneland, Anne; Halkjaer, Jytte; Boutron-Ruault, Marie-Christine; Artaud, Fanny; Severi, Gianluca; Kaaks, Rudolf; Schulze, Matthias B; Bergmann, Manuela M; Masala, Giovanna; Grioni, Sara; Simeon, Vittorio; Tumino, Rosario; Sacerdote, Carlotta; Skeie, Guri; Rylander, Charlotta; Borch, Kristin Benjaminsen; Quirós, J Ramón; Rodriguez-Barranco, Miguel; Chirlaque, Maria-Dolores; Ardanaz, Eva; Amiano, Pilar; Drake, Isabel; Stocks, Tanja; Häggström, Christel; Harlid, Sophia; Ellingjord-Dale, Merete; Riboli, Elio; Tsilidis, Konstantinos K.
Afiliación
  • Christakoudi S; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Pagoni P; MRC Centre for Transplantation, King's College London, London, UK.
  • Ferrari P; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Cross AJ; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Tzoulaki I; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Muller DC; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Weiderpass E; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Freisling H; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Murphy N; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Dossus L; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Turzanski Fortner R; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Agudo A; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Overvad K; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Perez-Cornago A; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Key TJ; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brennan P; Unit of Nutrition and Cancer. Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.
  • Johansson M; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Tjønneland A; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Halkjaer J; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Boutron-Ruault MC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Artaud F; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Severi G; International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Kaaks R; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Schulze MB; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Bergmann MM; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Équipe "Exposome, Hérédité, Cancer et Santé", CESP, Gustave Roussy, Villejuif, France.
  • Masala G; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Équipe "Exposome, Hérédité, Cancer et Santé", CESP, Gustave Roussy, Villejuif, France.
  • Grioni S; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Équipe "Exposome, Hérédité, Cancer et Santé", CESP, Gustave Roussy, Villejuif, France.
  • Simeon V; Department of Statistics, Computer Science, and Applications "G. Parenti" (DISIA), University of Florence, Florence, Italy.
  • Tumino R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sacerdote C; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Skeie G; Institute of Nutrition Science, University of Potsdam, Nuthetal, Germany.
  • Rylander C; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
  • Borch KB; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
  • Quirós JR; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Rodriguez-Barranco M; Dep. of Mental, Physical Health and Preventive Medicine University "L.Vanvitelli", Naples, Italy.
  • Chirlaque MD; Cancer Registry and Histopathology Department, Provincial Health Authority (ASP) Ragusa, Italy.
  • Ardanaz E; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Amiano P; Department of Community Medicine, UiT The Arctic university of Norway, Tromsø, Norway.
  • Drake I; Department of Community Medicine, UiT The Arctic university of Norway, Tromsø, Norway.
  • Stocks T; Department of Community Medicine, UiT The Arctic university of Norway, Tromsø, Norway.
  • Häggström C; Public Health Directorate, Asturias, Spain.
  • Harlid S; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • Ellingjord-Dale M; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Riboli E; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Tsilidis KK; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Int J Cancer ; 148(7): 1637-1651, 2021 04 01.
Article en En | MEDLINE | ID: mdl-33038275
ABSTRACT
Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval 1.05-1.23). Compared to stable weight (±0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sobrepeso / Neoplasias / Obesidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sobrepeso / Neoplasias / Obesidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Int J Cancer Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido